Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation.

Front Immunol · 2025 · PMC12861908 · PMID 41635842

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Use of post-transplant cyclophosphamide (PT-CY) showed a nonsignificant trend toward more frequent application in the early mortality group.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.